TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
214,394
|
266,583
|
301,938 |
| Earnings before taxes |
130,506
|
-285,535
|
-34,238 |
| Total assets |
429,017
|
282,441
|
465,318 |
| Current assets |
187,162
|
177,471
|
144,009 |
| Current liabilities |
321,653
|
274,157
|
147,308 |
| Equity capital |
21,777
|
-80,207
|
235,423 |
| - share capital |
26,944
|
26,969
|
27,030 |
| Employees (average) |
750
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.1%
|
-28.4%
|
50.6% |
| Turnover per employee |
286
|
762
|
863 |
| Profit as a percentage of turnover |
60.9%
|
-107.1%
|
-11.3% |
| Return on assets (ROA) | |||
| Current ratio |
58.2%
|
64.7%
|
97.8% |
| Return on equity (ROE) |
599.3%
|
356.0%
|
-14.5% |
| Change turnover |
-51,935
|
-34,683
|
60,874 |
| Change turnover % |
-20%
|
-12%
|
25% |
| Chg. No. of employees |
400
|
0
|
0 |
| Chg. No. of employees % |
114%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.